NYR 3.51% 5.9¢ nyrada inc.

Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-59

  1. 10,171 Posts.
    lightbulb Created with Sketch. 1982
    Don’t take it from me, it’s all available 3 weeks ago in the investor conference

    - phase 2 trials are next year and are in America and for both stroke and TBI together
    - Phase 2 will look to take the grant from the US department of defence after Walter reed
    - Phase 1 will do both Stroke and TBI on Australia
    - drug will be fast tracked because of its indication and no drug put there does what it does

    Hawk70 you’re trolling now and making things up again. Phase 1 is in human testing testing for safety and dosage and also if the drug is doing what it’s supposed to be doing on the brain.

    This isn’t a 10 million market cap drug and on the upside it’s where AGN is which is a 100 million dollar drug. Answer my question why is AGN a 100 million market cap? Also why is phase 1 completed in Australia and phase 2 that starts next year in America? I thought you need FDA phase 1 and they can’t start phase 2 for years and years hahaha Your lying again Hawk70

    https://youtu.be/Nbk__7w_6gw?si=5ZXBngbenfImg3pM
    Last edited by Roch2077: 10/05/24
 
watchlist Created with Sketch. Add NYR (ASX) to my watchlist
(20min delay)
Last
5.9¢
Change
0.002(3.51%)
Mkt cap ! $10.75M
Open High Low Value Volume
5.8¢ 5.9¢ 5.7¢ $6.913K 120.7K

Buyers (Bids)

No. Vol. Price($)
1 6000 5.6¢
 

Sellers (Offers)

Price($) Vol. No.
6.0¢ 7000 1
View Market Depth
Last trade - 15.16pm 28/06/2024 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.